WallStreetZenWallStreetZen

NASDAQ: ME
23andme Holding Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ME past revenue growth

How has ME's revenue growth performed historically?
Company
6.74%
Industry
1.91%
Market
13.73%
ME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ME's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ME earnings and revenue history

Current Revenue
$295.8M
Current Earnings
-$326.7M
Current Profit Margin
-110.4%

ME Return on Equity

Current Company
-44.2%
Current Industry
-75.3%
Current Market
22.1%
ME's Return on Equity (-44.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ME announces earnings.

ME Return on Assets

Current Company
-33.7%
Current Industry
5.6%
ME is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ME Return on Capital Employed

Current Company
-43.77%
Current Industry
10.3%

ME vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ME$295.84M-$294.06M-$326.75M+7.69%N/A
CSTL$167.52M-$77.05M-$88.85M+48.33%N/A
ACRS$31.17M-$104.52M-$105.32M+36.92%N/A
CDNA$309.31M-$73.54M-$83.97M+40.46%N/A
LAB$105.45M-$76.44M-$84.15M+0.25%N/A
View Top Diagnostic & Research Stocks

ME earnings dates

Next earnings date
Nov 7, 2023

23andme Holding Co Earnings & Revenue FAQ

What were ME's earnings last quarter?

On Invalid Date, 23andme Holding Co (NASDAQ: ME) reported Q2 2023 earnings per share (EPS) of -$0.23, up 15% year over year. Total 23andme Holding Co earnings for the quarter were -$104.62 million. In the same quarter last year, 23andme Holding Co's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy 23andme Holding Co stock.

What was ME's earnings growth in the past year?

As of Q3 2023, 23andme Holding Co's earnings has grown year over year. 23andme Holding Co's earnings in the past year totalled -$326.75 million.

What is ME's earnings date?

23andme Holding Co's earnings date is Invalid Date. Add ME to your watchlist to be reminded of ME's next earnings announcement.

What was ME's revenue last quarter?

On Invalid Date, 23andme Holding Co (NASDAQ: ME) reported Q2 2023 revenue of $60.86 million up 5.66% year over year. In the same quarter last year, 23andme Holding Co's revenue was $64.51 million.

What was ME's revenue growth in the past year?

As of Q3 2023, 23andme Holding Co's revenue has grown 6.74% year over year. This is 4.83 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.91%. 23andme Holding Co's revenue in the past year totalled $295.84 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.